Inhibition of HDAC increases the senescence induced by natural polyphenols in glioma cells

Biochemistry and Cell Biology

Volumn 92, Issue 4, 2014, Pages 297-304

  Vargas, José E ^a   Filippi Chiela, Eduardo C ^a   Suhre, Tais ^a   Kipper, Franciele C ^a   Bonatto, Diego ^a   Lenz, Guido ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Glioma; Quercetin; Resveratrol; Senescence; Sodium butyrate

Indexed keywords

CELL CULTURE; DISEASES; FLAVONOIDS; PROTEINS; RATS; RESVERATROL; SODIUM; VOLATILE FATTY ACIDS;

CELLULAR SENESCENCE; GLIOMA; HISTONE DEACETYLASES; PRIMARY BRAIN TUMORS; QUERCETIN; REACTIVE OXYGEN SPECIES; SENESCENCE; SODIUM BUTYRATE;

TUMORS;

BUTYRIC ACID; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HISTONE H2AX; PROTEIN P21; QUERCETIN; REACTIVE OXYGEN METABOLITE; RESVERATROL; ANTINEOPLASTIC AGENT; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; STILBENE DERIVATIVE;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; ASTROCYTE; CANCER INHIBITION; CELL AGING; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DRUG POTENTIATION; ENZYME INHIBITION; GLIOMA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; NONHUMAN; RAT; ANIMAL; DRUG EFFECTS; DRUG SCREENING; GLIOMA; METABOLISM; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; BUTYRIC ACID; CELL AGING; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DRUG SCREENING ASSAYS, ANTITUMOR; DRUG SYNERGISM; GLIOMA; HISTONE DEACETYLASE INHIBITORS; HUMANS; QUERCETIN; RATS; REACTIVE OXYGEN SPECIES; STILBENES;

EID: 84905571756     PISSN: 08298211     EISSN: 12086002     Source Type: Journal    
DOI: 10.1139/bcb-2014-0022     Document Type: Article

References (58)

1. Anderson E. Grant R. Lewis S.C. Whittle I.R. 2008. Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? Br. J. Neurosurg. 22 (3): 339-349. 10.1080/02688690701885603. 18568722.
2. Asensi M. Medina I. Ortega A. Carretero J. Bano M.C. Obrador E. Estrela J.M. 2002. Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic. Biol. Med. 33 (3): 387-398. 10.1016/S0891-5849(02) 00911-5. 12126761.
3. Baskar R. Lee K.A. Yeo R. Yeoh K.W. 2013. Cancer and radiation therapy: current advances and future directions. Int. J. Med. Sci. 9 (3): 193-199. 10.7150/ijms.3635. 22408567.
4. Benatar T. Yang W. Amemiya Y. Evdokimova V. Kahn H. Holloway C. Seth A. 2012. IGFBP7 reduces breast tumor growth by induction of senescence and apoptosis pathways. Breast Cancer Res. Treat. 133 (2): 563-573. 10.1007/s10549-011-1816-4. 21997538.
5. Bolden J.E. Peart M.J. Johnstone R.W. 2006. Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5 (9): 769-784. 10.1038/nrd2133. 16955068.
6. Braganhol E. Zamin L.L. Canedo A.D. Horn F. Tamajusuku A.S. Wink M.R. et al 2006. Antiproliferative effect of quercetin in the human U138MG glioma cell line. Anticancer Drugs, 17 (6): 663-671. 10.1097/01.cad.0000215063.23932.02. 16917212.
7. Brodska B. Holoubek A. 2011. Generation of reactive oxygen species during apoptosis induced by DNA-damaging agents and/or histone deacetylase inhibitors. Oxid. Med. Cell. Longev. 2011: 253529. 10.1155/2011/253529. 21949898.
8. Campisi J. d'Adda di Fagagna F. 2007. Cellular senescence: when bad things happen to good cells. Nat. Rev. Mol. Cell Biol. 8 (9): 729-740. 10.1038/nrm2233. 17667954.
9. Castino R. Pucer A. Veneroni R. Morani F. Peracchio C. Lah T.T. Isidoro C. 2011. Resveratrol reduces the invasive growth and promotes the acquisition of a long-lasting differentiated phenotype in human glioblastoma cells. J. Agric. Food Chem. 59 (8): 4264-4272. 10.1021/jf104917q. 21395220.
10. Chan S.T. Yang N.C. Huang C.S. Liao J.W. Yeh S.L. 2013. Quercetin enhances the antitumor activity of trichostatin A through upregulation of p53 protein expression in vitro and in vivo. PLoS One, 8 (1): e54255. 10.1371/journal.pone.0054255. 23342112.
11. Coradini D. Biffi A. Costa A. Pellizzaro C. Pirronello E. Di Fronzo G. 1997. Effect of sodium butyrate on human breast cancer cell lines. Cell Prolif. 30 (3-4): 149-159. 10.1111/j.1365-2184.1997.tb00931.x. 9375027.
12. de Boer V.C. Dihal A.A. van der Woude H. Arts I.C. Wolffram S. Alink G.M. et al 2005. Tissue distribution of quercetin in rats and pigs. J. Nutr. 135 (7): 1718-1725. 15987855.
13. Di Bernardo G. Squillaro T. Dell'Aversana C. Miceli M. Cipollaro M. Cascino A. et al 2009. Histone deacetylase inhibitors promote apoptosis and senescence in human mesenchymal stem cells. Stem Cells Dev. 18 (4): 573-581. 10.1089/scd.2008.0172. 18694296.
14. Dimri G.P. Lee X. Basile G. Acosta M. Scott G. Roskelley C. et al 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (20): 9363-9367. 10.1073/pnas.92.20. 9363. 7568133.
15. dos Santos M.P. Schwartsmann G. Roesler R. Brunetto A.L. Abujamra A.L. 2009. Sodium butyrate enhances the cytotoxic effect of antineoplastic drugs in human lymphoblastic T-cells. Leuk. Res. 33 (2): 218-221. 10.1016/j.leukres.2008. 07.003. 18692895.
16. Elknerova K. Myslivcova D. Lacinova Z. Marinov I. Uherkova L. Stockbauer P. 2011. Epigenetic modulation of gene expression of human leukemia cell lines-induction of cell death and senescence. Neoplasma, 58 (1): 35-44. 10.4149/neo-2011-01-35. 21067264.
17. Ewald J.A. Desotelle J.A. Wilding G. Jarrard D.F. 2010. Therapy-induced senescence in cancer. J. Natl. Cancer Inst. 102 (20): 1536-1546. 10.1093/jnci/djq364. 20858887.
18. Filippi-Chiela E.C. Oliveira M.M. Jurkovski B. Callegari-Jacques S.M. da Silva V.D. Lenz G. 2012 a. Nuclear morphometric analysis (NMA): screening of senescence, apoptosis and nuclear irregularities. PLoS One, 7 (8): e42522. 10.1371/journal.pone.0042522. 22905142.
19. Filippi-Chiela E.C. Villodre E.S. Zamin L.L. Lenz G. 2012 b. Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS One, 6 (6): e20849. 10.1371/journal.pone.0020849. 21695150.
20. Filippi-Chiela E.C. Thome M.P. Bueno e Silva M.M. Pelegrini A.L. Ledur P.F. Garicochea B. et al 2013. Resveratrol abrogates the temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the temozolomide-induced senescence in glioma cells. BMC Cancer, 13: 147. 10.1186/1471-2407-13-147. 23522185.
21. Gao Z. Xu M.S. Barnett T.L. Xu C.W. 2011. Resveratrol induces cellular senescence with attenuated mono-ubiquitination of histone H2B in glioma cells. Biochem. Biophys. Res. Commun. 407 (2): 271-276. 10.1016/j.bbrc.2011.02.008. 21481687.
22. Heiss E.H. Schilder Y.D. Dirsch V.M. 2007. Chronic treatment with resveratrol induces redox stress-and ataxia telangiectasia-mutated (ATM)-dependent senescence in p53-positive cancer cells. J. Biol. Chem. 282 (37): 26759-26766. 10.1074/jbc.M703229200. 17626009.
23. Hoeferlin L.A. Oleinik N.V. Krupenko N.I. Krupenko S.A. 2011. Activation of p21-Dependent G1/G2 Arrest in the Absence of DNA Damage as an Antiapoptotic Response to Metabolic Stress. Genes Cancer, 2 (9): 889-899. 10.1177/ 1947601911432495. 22593801.
24. Hu S. Chen R. Man X. Feng X. Cen J. Gu W. et al 2011. Function and expression of insulin-like growth factor-binding protein 7 (IGFBP7) gene in childhood acute myeloid leukemia. Pediatr. Hematol. Oncol. 28 (4): 279-287. 10.3109/08880018.2011.557852. 21413833.
25. Huang H. Lin H. Zhang X. Li J. 2012. Resveratrol reverses temozolomide resistance by downregulation of MGMT in T98G glioblastoma cells by the NF-kappaB-dependent pathway. Oncol. Rep. 27 (6): 2050-2056. 10.3892/or.2012. 1715. 22426504.
26. Ishii N. Maier D. Merlo A. Tada M. Sawamura Y. Diserens A.C. Van Meir E.G. 1999. Frequent co-alterations of TP53, p16/CDKN2A, p14ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol. 9 (3): 469-479. 10.1111/j.1750-3639.1999.tb00536.x. 10416987.
27. Jacques-Silva M.C. Bernardi A. Rodnight R. Lenz G. 2004. ERK, PKC and PI3K/Akt pathways mediate extracellular ATP and adenosine-induced proliferation of U138-MG human glioma cell line. Oncology, 67 (5-6): 450-459. 10.1159/000082930. 15714002.
28. Jeng J.H. Kuo M.Y. Lee P.H. Wang Y.J. Lee M.Y. Lee J.J. et al 2006. Toxic and metabolic effect of sodium butyrate on SAS tongue cancer cells: role of cell cycle deregulation and redox changes. Toxicology, 223 (3): 235-247. 10.1016/j.tox.2006.04.033. 16737765.
29. Jiang H. Zhang L. Kuo J. Kuo K. Gautam S.C. Groc L. et al 2005. Resveratrol-induced apoptotic death in human U251 glioma cells. Mol. Cancer Ther. 4 (4): 554-561. 10.1158/1535-7163.MCT-04-0056. 15827328.
30. Jiang W. Guo Q. Wu J. Guo B. Wang Y. Zhao S. et al 2012. Dual effects of sodium butyrate on hepatocellular carcinoma cells. Mol. Biol. Rep. 39 (5): 6235-6242. 10.1007/s11033-011-1443-5. 22228088.
31. Kato K. Kuhara A. Yoneda T. Inoue T. Takao T. Ohgami T. et al 2011. Sodium butyrate inhibits the self-renewal capacity of endometrial tumor side-population cells by inducing a DNA damage response. Mol. Cancer Ther. 10 (8): 1430-1439. 10.1158/1535-7163.MCT-10-1062. 21632462.
32. Kim E.H. Kim H.S. Kim S.U. Noh E.J. Lee J.S. Choi K.S. 2005. Sodium butyrate sensitizes human glioma cells to TRAIL-mediated apoptosis through inhibition of Cdc2 and the subsequent downregulation of survivin and XIAP. Oncogene, 24: 6877-6889. 10.1038/sj.onc.1208851. 16007142.
33. Kuilman T. Michaloglou C. Mooi W.J. Peeper D.S. 2010. The essence of senescence. Genes Dev. 24 (22): 2463-2479. 10.1101/gad.1971610. 21078816.
34. Kuo P.L. Chiang L.C. Lin C.C. 2002. Resveratrol-induced apoptosis is mediated by p53-dependent pathway in Hep G2 cells. Life Sci. 72 (1): 23-34. 10.1016/S0024-3205(02)02177-X. 12409142.
35. Lenz G. 2012. Endogenous anticancer mechanisms (EACMs). Front. Biosci. (Schol. Ed.), 4: 1017-1030. 10.2741/S315. 22202106.
36. Lenz G. Goncalves D. Luo Z. Avruch J. Rodnight R. Neary J.T. 2001. Extracellular ATP stimulates an inhibitory pathway towards growth factor-induced cRaf-1 and MEKK activation in astrocyte cultures. J. Neurochem. 77 (4): 1001-1009. 10.1046/j.1471-4159.2001.00299.x. 11359865.
37. Mah L.J. El-Osta A. Karagiannis T.C. 2010. gammaH2AX: a sensitive molecular marker of DNA damage and repair. Leukemia, 24 (4): 679-686. 10.1038/leu.2010.6. 20130602.
38. Minamiyama M. Katsuno M. Adachi H. Waza M. Sang C. Kobayashi Y. et al 2004. Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy. Hum. Mol. Genet. 13 (11): 1183-1192. 10.1093/hmg/ddh131. 15102712.
39. Murakami A. Ashida H. Terao J. 2008. Multitargeted cancer prevention by quercetin. Cancer Lett. 269 (2): 315-325. 10.1016/j.canlet.2008.03.046. 18467024.
40. Nogueira V. Park Y. Chen C.C. Xu P.Z. Chen M.L. Tonic I. et al 2008. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell, 14 (6): 458-470. 10.1016/j.ccr.2008.11.003. 19061837.
41. Pitozzi V. Mocali A. Laurenzana A. Giannoni E. Cifola I. Battaglia C. et al 2013. Chronic resveratrol treatment ameliorates cell adhesion and mitigates the inflammatory phenotype in senescent human fibroblasts. J. Gerontol. A Biol. Sci. Med. Sci. 68 (4): 371-381. 10.1093/gerona/gls183. 22933405.
42. Polewska J. Skwarska A. Augustin E. Konopa J. 2013. DNA-Damaging Imidazoacridinone C-1311 Induces Autophagy followed by Irreversible Growth Arrest and Senescence in Human Lung Cancer Cells. J. Pharmacol. Exp. Ther. 346 (3): 393-405. 10.1124/jpet.113.203851. 23823138.
43. Rahman A. Shahabuddin, Hadi S.M. Parish J.H. 1990. Complexes involving quercetin, DNA and Cu(II). Carcinogenesis, 11 (11): 2001-2003. 10.1093/carcin/11.11.2001. 2225332.
44. Rusin M. Zajkowicz A. Butkiewicz D. 2009. Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1. Mech. Ageing Dev. 130 (8): 528-537. 10.1016/j.mad.2009.06.005. 19559722.
45. Sakharkar M.K. Shashni B. Sharma K. Dhillon S.K. Ranjekar P.R. Sakharkar K.R. 2013. Therapeutic implications of targeting energy metabolism in breast cancer. PPAR Res. 2013: 109285. 10.1155/2013/109285. 23431283.
46. Siegelin M.D. Reuss D.E. Habel A. Rami A. von Deimling A. 2009. Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells. Neuro Oncol. 11 (2): 122-131. 10.1215/15228517-2008- 085. 18971417.
47. Tanigawa S. Fujii M. Hou D.X. 2008. Stabilization of p53 is involved in quercetin-induced cell cycle arrest and apoptosis in HepG2 cells. Biosci. Biotechnol. Biochem. 72 (3): 797-804. 10.1271/bbb.70680. 18323654.
48. Terao Y. Nishida J. Horiuchi S. Rong F. Ueoka Y. Matsuda T. et al 2001. Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells. Int. J. Cancer, 94 (2): 257-267. 10.1002/ijc.1448. 11668507.
49. Thaler S. Hahnel P.S. Schad A. Dammann R. Schuler M. 2009. RASSF1A mediates p21Cip1/Waf1-dependent cell cycle arrest and senescence through modulation of the Raf-MEK-ERK pathway and inhibition of Akt. Cancer Res. 69 (5): 1748-1757. 10.1158/0008-5472.CAN-08-1377. 19223555.
50. Tseng S.H. Lin S.M. Chen J.C. Su Y.H. Huang H.Y. Chen C.K. et al 2004. Resveratrol suppresses the angiogenesis and tumor growth of gliomas in rats. Clin. Cancer Res. 10 (6): 2190-2202. 10.1158/1078-0432.CCR-03-0105. 15041740.
51. van Heemst D. den Reijer P.M. Westendorp R.G. 2007. Ageing or cancer: a review on the role of caretakers and gatekeepers. Eur. J. Cancer, 43 (15): 2144-2152. 10.1016/j.ejca.2007.07.011. 17764928.
52. Vargas J. Feltes B.C. Poloni Jde F. Lenz G. Bonatto D. 2012. Senescence; an endogenous anticancer mechanism. Front. Biosci. 17: 2616-2643. 10.2741/4074. 22652801.
53. Wakabayashi K. Saito H. Ebinuma H. Saito Y. Takagi T. Nakamura M. et al 2000. Bcl-2 related proteins are dramatically induced at the early stage of differentiation in human liver cancer cells by a histone deacetylase inhibitor projecting an anti-apoptotic role during this period. Oncol. Rep. 7 (2): 285-288. 10.3892/or.7.2.285. 10671672.
54. Wood J.G. Rogina B. Lavu S. Howitz K. Helfand S.L. Tatar M. Sinclair D. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430 (7000): 686-689. 10.1038/nature02789. 15254550.
55. Yaseen A. Chen S. Hock S. Rosato R. Dent P. Dai Y. Grant S. 2012. Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway. Mol. Pharmacol. 82 (6): 1030-1041. 10.1124/mol.112.079624. 22923501.
56. Zamin L.L. Filippi-Chiela E.C. Dillenburg-Pilla P. Horn F. Salbego C. Lenz G. 2009. Resveratrol and quercetin cooperate to induce senescence-like growth arrest in C6 rat glioma cells. Cancer Sci. 100 (9): 1655-1662. 10.1111/j.1349-7006.2009.01215.x. 19496785.
57. Zamin L.L. Filippi-Chiela E.C. Vargas J. Demartini D.R. Meurer L. Souza A.P. et al 2014. Quercetin promotes glioma growth in a rat model. Food Chem. Toxicol. 63: 205-211. 10.1016/j.fct.2013.11.002. 24252772.
58. Zhang W. Fei Z. Zhen H.N. Zhang J.N. Zhang X. 2007. Resveratrol inhibits cell growth and induces apoptosis of rat C6 glioma cells. J. Neurooncol. 81 (3): 231-240. 10.1007/s11060-006-9226-x. 17031560.